Clinical Trials Logo

CKD Stage 3b clinical trials

View clinical trials related to CKD Stage 3b.

Filter by:
  • None
  • Page 1

NCT ID: NCT03596749 Not yet recruiting - CKD Stage 4 Clinical Trials

The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4

Start date: September 1, 2018
Phase: Phase 3
Study type: Interventional

The aim of this study is to investigate effects of sevelamer carbonate on reducing TMAO in stage 3b-4 CKD (pre-dialysis) patients. The study will also investigate the safety and tolerability of sevelamer carbonate in study population and the effects of sevelamer carbonate on serum p-cresyl sulfate, indoxyl sulfate, LDL-C and uric acid.